Jiehua Deng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jiehua Deng has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Bin Liang
Department of Gastroenterology, Minzu Hospital of Guangxi Medical University, Nanning, China
1 shared publication- Bin Liang
Department of Gastroenterology, Minzu Hospital of Guangxi Medical University, Nanning, China
1 shared publication - Jianchao Ma
Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
1 shared publication Jianquan Zhang
Department of Respiratory and Critical Medicine, The Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China
1 shared publication- Jiansheng Huang
Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530000, China
1 shared publication Lixia Wei
Department of Cardiovascular Medicine, the Second People's Hospital of Qinzhou, Qinzhou, China
1 shared publication
Latest Publications
- 5 September 2026
- Published by European Respiratory Society (ERS)
- Vol. 68 (suppl 70) , PA5828
Aspirin reduces the mortality risk of patients combined with chronic obstructive pulmonary disease and heart failure: a retrospective cohort study based on MIMIC IV database
Objective: This study aimed to investigate the association between aspirin use and outcome indicators in patients combined with chronic obstructive pulmonary disease and heart failure (COPD-HF). Methods: Data from COPD-HF patients were extracted from the MIMIC-IV database. Propensity score matching (PSM) was employed to minimize confounding biases after multiple imputations of missing data. Baseline characteristics and outcomes were compared between the aspirin users group and the aspirin non-users group. Logistic regression, Cox proportional hazard (Cox) regression, Kaplan-Meier (KM) survival analysis and Restricted cubic splines (RCS) were used to explore the relationship between aspirin use and outcome indicators. Results: A total of 1753 COPD-HF patients were included. Among 1350 propensity score-matched patients, the distribution of different outcome indicators and multivariate logistic regression revealed that aspirin use was associated with lower in-hospital and 1-year mortality (p < 0.05). Both Cox regression and KM analyses confirmed that aspirin use significantly reduced in-hospital mortality, but there was no significant difference in 1-year mortality. Subgroup analysis showed that aspirin use notably decreased in-hospital mortality in females, whites, non-smokers, and non-drinkers. Cox regression showed that in-hospital and 1-year mortality were independent of aspirin dose. RCS showed that there was a linear relationship between aspirin use duration and in-hospital and 1-year mortality (non-linear p > 0.05). Conclusions: Aspirin use significantly reduces in-hospital mortality. Aspirin dosage is not associated with in-hospital mortality, while duration of use shows a linear correlation with mortality risk.
- 5 September 2026
- Published by European Respiratory Society (ERS)
- Vol. 68 (suppl 70) , PA5828
Aspirin reduces the mortality risk of patients combined with chronic obstructive pulmonary disease and heart failure: a retrospective cohort study based on MIMIC IV database
Objective: This study aimed to investigate the association between aspirin use and outcome indicators in patients combined with chronic obstructive pulmonary disease and heart failure (COPD-HF). Methods: Data from COPD-HF patients were extracted from the MIMIC-IV database. Propensity score matching (PSM) was employed to minimize confounding biases after multiple imputations of missing data. Baseline characteristics and outcomes were compared between the aspirin users group and the aspirin non-users group. Logistic regression, Cox proportional hazard (Cox) regression, Kaplan-Meier (KM) survival analysis and Restricted cubic splines (RCS) were used to explore the relationship between aspirin use and outcome indicators. Results: A total of 1753 COPD-HF patients were included. Among 1350 propensity score-matched patients, the distribution of different outcome indicators and multivariate logistic regression revealed that aspirin use was associated with lower in-hospital and 1-year mortality (p < 0.05). Both Cox regression and KM analyses confirmed that aspirin use significantly reduced in-hospital mortality, but there was no significant difference in 1-year mortality. Subgroup analysis showed that aspirin use notably decreased in-hospital mortality in females, whites, non-smokers, and non-drinkers. Cox regression showed that in-hospital and 1-year mortality were independent of aspirin dose. RCS showed that there was a linear relationship between aspirin use duration and in-hospital and 1-year mortality (non-linear p > 0.05). Conclusions: Aspirin use significantly reduces in-hospital mortality. Aspirin dosage is not associated with in-hospital mortality, while duration of use shows a linear correlation with mortality risk.
- Open Access
- 1 January 2026
- Published by KEAI Publishing in Genes & Diseases
- Vol. 13 (1) , 101620
Bioinformatic validation and machine learning based exploration of B cells-related gene signatures in the context of strategies for precision therapy to acute myeloid leukemia
- 1 January 2026
- Published by KEAI Publishing in Genes & Diseases
- Vol. 13 (1) , 101620
Open AccessBioinformatic validation and machine learning based exploration of B cells-related gene signatures in the context of strategies for precision therapy to acute myeloid leukemia